HomeGANX • NASDAQ
add
Gain Therapeutics Inc
Previous close
$1.88
Day range
$1.84 - $1.95
Year range
$0.89 - $3.19
Market cap
52.66M USD
Avg Volume
273.04K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | -6.57M | -4.13% |
Net income | -3.77M | 20.23% |
Net profit margin | — | — |
Earnings per share | -0.08 | 72.41% |
EBITDA | -3.32M | 24.38% |
Effective tax rate | -15.47% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.39M | -38.16% |
Total assets | 12.12M | -34.85% |
Total liabilities | 4.78M | -20.67% |
Total equity | 7.34M | — |
Shares outstanding | 27.79M | — |
Price to book | 6.96 | — |
Return on assets | -62.91% | — |
Return on capital | -94.31% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -3.77M | 20.23% |
Cash from operations | -3.45M | 38.97% |
Cash from investing | -43.45K | -101.38% |
Cash from financing | 2.31M | -75.81% |
Net change in cash | -1.67M | -122.14% |
Free cash flow | -1.89M | 36.57% |
About
Founded
2017
Website
Employees
24
